Enabling cutting-edge
aging & longevity research
The Clock Foundation is making epigenetic aging clocks more accessible for use with preclinical and clinical studies. This includes newer measures that help predict future healthspan and lifespan, such as PhenoAge and GrimAge, as well as epigenetic clocks for diverse mammalian species.
Applications for Companion Pets & Diverse Mammalian Species
Universal mammalian aging clocks, for not only humans but also dogs, cats, whales, dolphins, and more than 150 additional species.
The Horvath Mammalian Methylation Array enables research across the entire mammalian tree of life - from understanding companion pet health and lifespan to wildlife conservation biology and comparative aging science.
Read MoreClock Foundation Resources
One of the key parts of our mission is to make epigenetic aging clocks and other key biomarkers of aging more accessible to researchers, companies, physicians, and patients.
Background on Aging Biomarkers
Understand the science behind epigenetic clocks, DNA methylation, and how biological age differs from chronological age.
Epigenetic Clocks for Clinical Trials
How to integrate GrimAge, PhenoAge, and DunedinPACE as primary or secondary endpoints in your clinical trial design.
Custom DNA Methylation Projects
Partner with us for bespoke methylation array design, data analysis, and bioinformatics support for your unique research needs.
Enabling Individuals, Physicians, and Clinical Research Leaders to Monitor Key Biomarkers of Aging
Our platform integrates epigenetics, clinical labs, wearables, and functional testing into a unified longitudinal view of biological aging - for individual patients and large-scale studies alike.
How to Get StartedOur Team & Advisors
Leadership
UCLA Professor in Human Genetics and Biostatistics. Primary developer of epigenetic aging clocks, including the pan-tissue Horvath Clock, PhenoAge, and GrimAge.
Bioengineer and biotech entrepreneur. B.S. Electrical & Biomedical Engineering (Georgia Tech), M.S. Biomedical Engineering (UCLA). Also CEO & CTO at Intervene Immune.
Former Horvath Lab post-doctoral researcher at UCLA. Specializes in epigenetic data analysis and methylation array bioinformatics pipelines.
Scientific Advisory Board
University of Edinburgh
Asst. Prof. University of Hawaiʻi; Adj. UCLA Epidemiology
Group Leader, Cellular Biology, Public Health England
EPA, Duke & UNC Chapel Hill
CSO, 21st Century Medicine & Intervene Immune
Join the Longevity Research Community
We're active today with basic research into the mechanisms of aging and ongoing studies of many new interventions. Let us know if you're interested in job, internship, or volunteer opportunities.
Enabling Individuals, Physicians, and Clinical Research Leaders to Monitor Key Biomarkers of Aging.